Form 4: CVS Health Director Nancy-Ann DeParle Acquires Shares and Holds Deferred Stock Compensation

CVS Health director Nancy-Ann DeParle acquired 2,331 shares of common stock and holds deferred stock compensation.

Summary

• Nancy-Ann DeParle, a director at CVS Health, acquired 2,331 shares of common stock on November 21, 2024, at a price of $57.1 per share.
• This acquisition was part of a semi-annual retainer payment under the company's 2017 Incentive Compensation Plan.
• DeParle also holds deferred stock compensation equivalent to 3,635.0665 shares of common stock.
• Following the transaction, DeParle directly owns 34,169 shares of CVS Health common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed positively as it aligns director interests with shareholders. There are no negative implications.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future.
• The use of stock as part of compensation aligns director interests with shareholder value.

Industry Context

This is a routine filing related to director compensation and is typical for publicly traded companies. It reflects standard practice for aligning director interests with company performance through equity-based compensation.

Comparison to Industry Standards

• Equity-based compensation for directors is a common practice across the healthcare industry, with companies like Walgreens Boots Alliance and UnitedHealth Group also utilizing similar methods.
• The use of stock grants and deferred stock units is a standard approach to incentivize directors and align their interests with those of shareholders.
• The specific amount of shares and the value are within the typical range for director compensation at large cap companies.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it demonstrates director confidence in the company.
• The use of stock-based compensation aligns director interests with shareholder value.

Key Dates

Keywords

CVS Health, Director, Stock Acquisition, Incentive Compensation, Deferred Stock, Form 4, Insider Trading